Volume 70, Issue 1, Pages (January 2019)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Hepatitis E virus infection and acute non-traumatic neurological injury: A prospective multicentre study Harry R. Dalton, Jeroen J.J. van Eijk, Pascal.

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

The impact of hepatitis E in the liver transplant setting

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

Volume 65, Issue 1, Pages S82-S94 (October 2016)

Inflammasomes in liver diseases

Volume 61, Issue 4, Pages (October 2014)

Volume 50, Issue 4, Pages (April 2009)

MELD: the holy grail of organ allocation?

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen? Patrick Marcellin, E. Jenny Heathcote,

Volume 65, Issue 5, Pages (November 2016)

Volume 68, Issue 5, Pages (May 2018)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Volume 51, Issue 6, Pages (December 2009)

The impact of hepatitis E in the liver transplant setting

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

J. Ambrosioni, A. Mamin, A. Hadengue, M. Bernimoulin, K. Samii, C

Volume 65, Issue 1, Pages S82-S94 (October 2016)

Immigration and viral hepatitis

Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis Astrid Marot, Jean Henrion, Jean-François.

Virological tools to diagnose and monitor hepatitis C virus infection

Volume 66, Issue 1, Pages 1-4 (January 2017)

Ype P. de Jong, Charles M. Rice, Alexander Ploss Journal of Hepatology

Living donor liver transplantation: is the hype over?

David G. Bowen, Christopher M. Walker Journal of Hepatology

Volume 69, Issue 2, Pages (August 2018)

Volume 44, Pages S19-S24 (January 2006)

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection Anaïs Vallet-Pichard,

The place of downstaging for hepatocellular carcinoma

Volume 140, Issue 5, Pages (May 2011)

Autoimmune hepatitis: A life-long disease

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

Volume 154, Issue 4, Pages (March 2018)

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 70, Issue 1, Pages (January 2019)

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Acute hepatitis C: Current status and remaining challenges

Management of cirrhosis due to chronic hepatitis C

Genomic risk of hepatitis C-related hepatocellular carcinoma

Darius Moradpour, Arash Grakoui, Michael P. Manns

Autophagy in the liver Journal of Hepatology

Volume 65, Issue 2, Pages (August 2016)

EASL Clinical Practice Guidelines on hepatitis E virus infection

Volume 50, Issue 4, Pages (April 2009)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Volume 56, Issue 6, Pages (June 2012)

Volume 50, Issue 3, Pages (March 2009)

Immigration and viral hepatitis

HCV targeting of patients with cirrhosis

Volume 63, Issue 1, Pages (July 2015)

Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection Isabelle Chemin,

Volume 51, Issue 2, Pages (August 2009)

Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences Zobair M. Younossi, Aybike Birerdinc,

Alessio Aghemo, Maria Francesca Donato Gastroenterology

Chronic hepatitis B in children and adolescents

Liver transplantation in children

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Volume 139, Issue 5, Pages (November 2010)

Volume 62, Issue 5, Pages (May 2015)

MELD: the holy grail of organ allocation?

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Volume 70, Issue 1, Pages 206-209 (January 2019) Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients Olivier Marion, Sébastien Lhomme, Arnaud Del Bello, Florence Abravanel, Laure Esposito, Anne Laure Hébral, Laurence Lavayssière, Olivier Cointault, David Ribes, Jacques Izopet, Nassim Kamar Journal of Hepatology Volume 70, Issue 1, Pages 206-209 (January 2019) DOI: 10.1016/j.jhep.2018.09.011 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Outcome of Hepatitis E virus-infected solid-organ-transplant recipients treated by ribavirin. HEV, hepatitis E virus; SVR, sustained virological response; RBV, ribavirin. Journal of Hepatology 2019 70, 206-209DOI: (10.1016/j.jhep.2018.09.011) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions